Arizona Tribune - BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)

The ETTAC is a U.S. Department of Commerce committee that serves as an advisory body to the Environmental Trade Working Group (ETWG) of the Trade Promotion Coordinating Committee (TPCC), reporting through the Secretary of Commerce in her capacity as Chair of the TPCC, on trade policies and programs affecting the U.S. environmental technology industry, including programs to promote export of environmental technologies and services. ETTAC members are selected from industry-leading companies across sectors including water and wastewater treatment, air quality control, and solid waste management and recycling. Learn more at https://www.trade.gov/ettac.

On December 11, 2024, the Department of Commerce issued a press release announcing the ETTAC committee appointments for the 2024-2026 term: https://www.commerce.gov/news/press-releases/2024/12/us-secretary-commerce-appoints-new-advisors-environmental-technologies

"The U.S. environmental technologies sector represents $432 billion in revenue and employs 1.8 million American workers - making it a vital industry for driving innovation and positioning the United States as a global leader in environmental technologies," said Secretary Raimondo. "I look forward to receiving the committee's recommendations on approaches for how the Department can continue supporting the competitiveness of American environmental technologies."

Mr. Calvert, who will serve a two-year term on the ETTAC, commented, "I am honored to serve the Secretary of Commerce and advocate for programs that foster the expanded use of innovative technologies to safeguard the environment and human health."

He continued, "American innovators lead the world in the development of newer and better environmental technologies to address challenges such as sustainable water treatment targeting emerging contaminants like per- and polyfluoroalkyl substances (PFAS). Now is the time to promote the export of these technologies around the world to address these global issues."

Learn more about BioLargo's environmental technologies at www.biolargo.com.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
[email protected]
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

SOURCE: BioLargo, Inc.

Y.Baker--AT